Contact Kai

Speaking Engagements

  

Turbocharge the Development of Best-in-Class Antibody & Cell-Based Approaches of Innate Immune Therapies, to Launch Safe, Globally Scalable & Efficacious Therapies from Europe The momentum of innate immune cell R&D is growing exponentially to harness innate immune responses in oncology, realise scaled allogeneic manufacturing, and drive commercial

18-20 October 2022
  

Dedicated to driving cost-effective, efficacious, safe, durable, scalable, and globally accessible allogeneic, cell-based, and engager therapies, the 8th Innate Killer Summit returns to cement your end-to-end education in innate immune therapeutics.

28-30 March 2023